The country of origin of water and blood filters
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- Accordingly, the country of origin of the water and blood filters will be the United States, which is where the Fiber Bundles are manufactured.
Ruling text
In your letter dated July 14, 2025, on behalf of your client, Medica USA Inc., you requested a country of origin ruling on water and blood filters. Descriptive literature was provided for our review. The items under consideration are described as water and blood filters. The water filter products are used to filter dialysis water, pharmaceutical water, domestic water, and wastewater. The blood filter products are used to filter blood and plasma.
The items come in a range of sizes with different fiber membrane filtration ranges to suit the specific filtration needs of the various applications. For each of the filters, the manufacturing process is substantially similar. U.S.-origin Fiber Bundles and Tunisian-origin plastic parts and components are exported to Italy for further processing into the finished merchandise.
Once these components are received in Italy, the local team begins prepping the materials by putting Fiber Bundles into filter cases and cutting off excess fiber ends. The Fiber Bundles undergo a potting process, which is the procedure where urethane is added to the ends of the units and then cut. The products then undergo leak testing to ensure integrity before final packaging. For blood filters, there is an additional sterilization step followed by an aeration step.
The Fiber Bundles are the component that imparts the filtration capabilities and are manufactured in the United States through a specialized process that involves using a blend of solvents, polymers, and additives, and use a unique spinneret to form the semi-permeable hollow fiber membranes with the right pore sizes for filtration. The solvents, polymers, and additives are blended to create a dope (or casting) solution.
This solution is then extruded by specialized pumps through a manufacturing process known as “spinning capillary membranes by phase inversion” to produce ultrafiltration and microfiltration membranes with microscopic or nanoscale pores for filtering. The dope solution extruded by the pumps is passed through the spinneret along with a specified diluent (or precipitating) solution using a dry-wet spinning phase-inversion technique.
The forming hollow-fiber membranes are then passed through an air gap (i.e., the space between the spinneret and a temperature-controlled coagulating bath) and then dropped into a coagulation bath. After this bath, the hollow-fiber membranes are transported by rollers and put through a solvent removal and drying process and then wound to specified fiber counts to form the finished Fiber Bundles.
The resulting Fiber Bundles have the micro or nano pore size specifications necessary for the specific filtration application. When determining the country of origin, the substantial transformation analysis is applicable. See, e.g., Headquarters Ruling Letter H301619, dated November 6, 2018. The test for determining whether a substantial transformation will occur is whether an article emerges from a process with a new name, character, or use different from that possessed by the article prior to processing.
See Texas Instruments Inc. v. United States, 681 F.2d 778 (C.C.P.A. 1982).
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N351307).